Looks like its time to load up on IDIX as VRTX was given the kiss of death...
Vertex Pharmaceuticals (VRTX - commentary - Cramer's Take): "Absolutely way ahead of the game [on hepatitis C] . Two thumbs up, way up. Cramer said it's in "the pantheon of biotech."
Market Data 
Markets 
AI
